CorVel Q2 Revenue Up 11% to $267M, EPS Up 24% to $0.67
CRVL sits 86% above its 52-week low of $44.83.
Summary
CorVel reported second-quarter revenue of $267 million (up 11%) and diluted EPS of $0.67 (up 24%), with $270 million of cash, no debt, and $18.1 million of buybacks in the quarter.
Key Events · Earnings and Guidance · CRVL
-
Q2 Revenue Up 11% to $267M
Revenue rose to $267.1 million from $239.6 million in the September 2025 quarter; six-month revenue was $527.1 million versus $474.4 million.
-
EPS Up 24%, Margin Expands
Diluted EPS was $0.67 versus $0.54, and gross profit rose 24% to $72.3 million at a 27% gross margin, up from $58.2 million a year earlier.
-
$270M Cash, No Borrowings
The company ended the quarter with $270 million of cash and cash equivalents and no debt; it repurchased $18.1 million of common stock during the quarter.
-
CERIS Adds Top 10 Health Plan
CERIS implemented an additional Top 10 national health plan and formed a partnership giving it access to the Blue Cross Blue Shield market, alongside new Hospital Bill Audit and Professional Claims products.
Analysis · CRVL · Finance
CorVel delivered 11% revenue growth and a 24% increase in diluted EPS year over year, while gross margin expanded to 27% from roughly 24%. The balance sheet backs it up: $270 million of cash and no borrowings. Buybacks of $18.1 million in the quarter reduced the share count (50.5 million basic vs 51.3 million a year ago), adding support to per-share growth. The offsetting signal is insider activity: 10% owner Corstar Holdings and other insiders have sold roughly $16.3 million of stock over the past 90 days under pre-set 10b5-1 plans, so operating momentum is arriving while large holders trim.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CRVL was trading at $83.23 on NASDAQ in the Finance sector, with a market capitalization of approximately $4.2B. The 52-week trading range was $44.83 to $85.15. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.